MicroRNA in ischemic stroke etiology and pathology
Tóm tắt
Small, noncoding, microRNAs (miRNAs) have emerged as key mediators of posttranscriptional gene silencing in both pathogenic and pathological aspects of ischemic stroke biology. In stroke etiology, miRNA have distinct expression patterns that modulate pathogenic processes including atherosclerosis (miR-21, miR-126), hyperlipidemia (miR-33, miR-125a-5p), hypertension (miR-155), and plaque rupture (miR-222, miR-210). Following focal cerebral ischemia, significant changes in the miRNA transcriptome, independent of an effect on expression of miRNA machinery, implicate miRNA in the pathological cascade of events that include blood brain barrier disruption (miR-15a) and caspase mediated cell death signaling (miR-497). Early activation of miR-200 family members improves neural cell survival via prolyl hydroxylase mRNA silencing and subsequent HIF-1α stabilization. Pro- (miR-125b) and anti-inflammatory (miR-26a, -34a, -145, and let-7b) miRNA may also be manipulated to positively influence stroke outcomes. Recent examples of successfully implemented miRNA-therapeutics direct the future of gene therapy and offer new therapeutic strategies by regulating large sets of genes in related pathways of the ischemic stroke cascade.
Từ khóa
Tài liệu tham khảo
Mackay J , Mensah GA , Mendis S , Greenlund K World Health Organization.The Atlas of Heart Disease and Stroke. Geneva: World Health Organization, 2004, p. 112.
O'Brien ER, 1994, Am J Pathol, 145, 883
Rink C, Antioxid Redox Signal
Trogan E, 2005, Methods Mol Biol, 293, 221
Xu CC, 2008, Sheng Li Xue Bao, 60, 553